Oliceridine in Patients With Acute Burn Injuries

Clinical trial NCT05465226 · COMPLETED

Trial details

NCT number: NCT05465226
Sponsor: University of Tennessee
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Pain Burns Adverse Drug Event Respiratory Depression Nausea and Vomiting, Postoperative

Start date: 2023-04-01
Primary completion: 2023-09-30
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.